The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review.
Ulrikke Lyng BeauchampHelle PappotCecilie Holländer-MieritzPublished in: JMIR mHealth and uHealth (2020)
We found that definitions of outcome measures and adherence varied across studies, and limited consensus among studies existed on which variables to monitor during treatment. Less heterogeneity, better consensus in terms of the use of wearables, and established standards for the definitions of wearable outcomes and adherence would improve comparisons of outcomes from studies using wearables. Adherence, and the definition of such, seems crucial to conclude on data from wearable studies in oncology. Additionally, research using advanced wearable devices and active use of the data are encouraged to further explore the potential of wearables in oncology during treatment. Particularly, randomized clinical studies are warranted to create consensus on when and how to implement in oncological practice.
Keyphrases
- systematic review
- clinical trial
- case control
- palliative care
- heart rate
- primary care
- electronic health record
- healthcare
- clinical practice
- glycemic control
- open label
- randomized controlled trial
- type diabetes
- blood pressure
- big data
- risk assessment
- double blind
- single cell
- prostate cancer
- phase ii
- phase iii
- data analysis
- machine learning
- weight loss
- skeletal muscle
- minimally invasive
- human health